Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-29
2011-03-29
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07915290
ABSTRACT:
Formulations comprising argatroban and methods of making and using the formulations are provided. In an embodiment, the formulation comprises a solution having an argatroban concentration ranging from greater than about 10 to about 500 mg/mL. The solution can comprise an aqueous solution. The solution can be packaged in a sealed container that may either be aseptically-filled or subjected to sterilization to reduce the microbiological burden of the formulation. The solution can further be diluted and administered to persons needing same.
REFERENCES:
patent: 4227006 (1980-10-01), Okamoto et al.
patent: 5214052 (1993-05-01), Ofuchi et al.
patent: 5506241 (1996-04-01), Mano et al.
patent: 5565471 (1996-10-01), Ozaki
patent: 5605892 (1997-02-01), Ikejiri et al.
patent: 5679690 (1997-10-01), Andre et al.
patent: 5849843 (1998-12-01), Laurin
patent: 5998019 (1999-12-01), Rosenbaum
patent: 6087375 (2000-07-01), Bridon
patent: 7589106 (2009-09-01), Palepu
patent: 2007/0049617 (2007-03-01), Owoo et al.
patent: 0008746 (1980-03-01), None
patent: 0301970 (1989-02-01), None
patent: 0565897 (1993-10-01), None
patent: 0608828 (1994-08-01), None
patent: 0608831 (1994-08-01), None
patent: 0621036 (1994-10-01), None
patent: 0669131 (1995-08-01), None
patent: 1031656 (1989-02-01), None
patent: WO 0067772 (2000-11-01), None
patent: 2005009361 (2005-02-01), None
patent: 2005009371 (2005-02-01), None
patent: 2007027565 (2007-03-01), None
GSKARL3-Search performed for acetic acid dissolve argatroban, [online], [retrieved on Aug. 18, 2008], Retrieved from the internet;,URL:http://us.gsk.com/products/assets/us-argatroban.pdf>.
Remington—The sciences and Practice of Pharmacy, 20th edition, 2000.
Argatroban—Wikipedia, the free encyclopedia; http://en.wikipedia.org/wiki/Argatroban dated May 16, 2007 (2 pgs.).
Mechanism of Action; Anticoagulant Therapy—Argatroban Mechanism of Action; http://www.argatroban.com/argatroban—mechanism.htm dated May 16, 2007 (1 pg.).
Dosage & Administration; Argatroban Dosage & Administration; http://www.argatroban.com/argatroban—dosage.htm dated May 16, 2007 (3 pgs.).
Written Opinion of the International Searching Authority (6 pgs.).
Burgos Richard A.
Owoo George
Baxter Healthcare S.A.
Baxter International Inc.
Henley, III Raymond J
K&L Gates LLP
LandOfFree
Argatroban formulations and methods for making and using same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Argatroban formulations and methods for making and using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Argatroban formulations and methods for making and using same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2663839